Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Astellas Pharma
(4503.TSE) Q2 2023
Earnings
4503.TSE
Apr 27
Confirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-25
-4
18
39
Details
Expected EPS
-14
Actual EPS
-25
Surprise EPS
-12
Surprise Percent
-82.33%
Description
Astellas Pharma (4503.TSE) has reported earnings of -25 per share for Q2 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login